In Reply: We clearly acknowledged all of the
methodological limitations cited by Dr Anon and colleagues. For example, we
were unable to confirm the actual diagnosis of acute bacterial sinusitis and
therefore patients included in our study may not have had this diagnosis.
However, it is common in clinical practice to initiate antimicrobial therapy
for presumed sinusitis without confirmation from radiological or microbiological
studies. Time to resolution of symptoms is but one of many reasonable outcomes
to select for the definition of treatment response in sinusitis. We selected
the absence of a claim for a second antibiotic within 28 days as our primary
outcome measure. This outcome is clinically reasonable and has been used in
other studies using pharmacy and administrative databases.1
We agree that the failure to define severity of disease was a limitation of
our study. However, given the particular subset of patients with sinusitis
in our study, we believe this was a minor limitation. For example, the Sinus
and Allergy Health Partnership (SAHP)2 antibiotic
treatment guidelines for patients similar to ours—those with acute sinusitis
and no antibiotic use in the prior 4 to 6 weeks—make no distinction
in recommended antibiotics based on symptom severity. The SAHP-recommended
antibiotics are amoxicillin, amoxicillin/clavulanate potassium, cefpodoxime
proxetil, and cefuroxime axetil.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.